Advanced company searchLink opens in new window

OMASS THERAPEUTICS LIMITED

Company number 10028228

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
02 Apr 2024 CS01 Confirmation statement made on 12 March 2024 with updates
12 Dec 2023 SH08 Change of share class name or designation
07 Dec 2023 SH01 Statement of capital following an allotment of shares on 7 December 2023
  • GBP 69,817.693
23 Nov 2023 SH01 Statement of capital following an allotment of shares on 12 November 2023
  • GBP 69,816.988
11 Oct 2023 SH08 Change of share class name or designation
18 Sep 2023 SH08 Change of share class name or designation
10 Jul 2023 SH08 Change of share class name or designation
05 Jun 2023 AA Accounts for a small company made up to 31 December 2022
19 May 2023 MA Memorandum and Articles of Association
19 May 2023 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES01 ‐ Resolution of adoption of Articles of Association
15 May 2023 AP01 Appointment of Mr James Arthur Geraghty as a director on 9 May 2023
24 Apr 2023 SH08 Change of share class name or designation
24 Apr 2023 SH08 Change of share class name or designation
20 Apr 2023 SH01 Statement of capital following an allotment of shares on 18 April 2023
  • GBP 69,816.988
03 Apr 2023 CS01 Confirmation statement made on 21 March 2023 with updates
27 Mar 2023 SH01 Statement of capital following an allotment of shares on 9 February 2023
  • GBP 66,308.216
21 Mar 2023 AD01 Registered office address changed from Schrödinger Building Heatley Road Oxford Science Park Oxford OX4 4GE England to Building 4000 John Smith Drive Oxford Business Park South Oxford OX4 2GX on 21 March 2023
10 Mar 2023 RP04SH01 Second filing of a statement of capital following an allotment of shares on 19 April 2022
  • GBP 64,972.246
22 Dec 2022 MR04 Satisfaction of charge 100282280001 in full
13 May 2022 PSC05 Change of details for Oxford Science Enterprises Plc as a person with significant control on 24 July 2019
12 May 2022 PSC05 Change of details for a person with significant control
12 May 2022 PSC05 Change of details for Oxford Sciences Innovation Plc as a person with significant control on 30 September 2021
10 May 2022 PSC05 Change of details for Syncona Limited as a person with significant control on 19 April 2022
09 May 2022 SH01 Statement of capital following an allotment of shares on 19 April 2022
  • GBP 64,972.246
  • ANNOTATION Clarification a second filed SH01 was registered on 10/03/2023.
26 Apr 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES13 ‐ Re-company business 15/10/2020
  • RES01 ‐ Resolution of adoption of Articles of Association